JF
IGMS

Jump Financial’s IGM Biosciences IGMS Stock Holding History

Jump Financial’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,200
Closed -$132K – 1860
2024
Q2 		$132K Buy
+19,200
New +$164K ﹤0.01% 1618
2023
Q3 		– Sell
-19,783
Closed -$183K – 2027
2023
Q2 		$183K Buy
+19,783
New +$222K 0.01% 1538
2022
Q4 		– Sell
-26,900
Closed -$612K – 1792
2022
Q3 		$612K Buy
26,900
+841
+3% +$17K 0.02% 810
2022
Q2 		$470K Buy
+26,059
New +$465K 0.02% 881

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jump Financial's IGMS Position: Q3 2024 in Review

Jump Financial sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 19,200 shares — an estimated $132K sold.

Jump Financial first reported a position in IGMS in Q2 2022 and held it in 4 quarters. The position peaked at $612K in Q3 2022. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Jump Financial reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 19,200 IGM Biosciences shares in Q3 2024, an estimated $132K.
  • Jump Financial first reported a position in IGM Biosciences in Q2 2022 and held it in 4 quarters.
  • Jump Financial's IGM Biosciences position peaked at $612K in Q3 2022.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.